The 12 mg arm reached 20.8% average body weight loss in adults with obesity or overweight and type 2 diabetes, and 22.6% in adults with severe obesity and established cardiovascular disease
fat, even if the number on the traditional scale doesnt seem to budge
Microdosing approaches Some researchers with multiple medical conditions, including thyroid disorders, prefer starting with microdosing tirzepatide to minimize side effects and assess tolerance before standard dosing
Some studies note potential additional effects like lower risks for certain conditions, though long-term data continues to evolve
Panic attacks can cause chest pain along with other symptoms like a fast heartbeat, sweating, dizziness, and shortness of breath
The higher bioavailability translates to more predictable therapeutic exposure